Perioperative nivolumab (NIVO) vs placebo (PBO) in patients (pts) with resectable NSCLC: Updated survival and biomarker analyses from CheckMate 77T Meeting Abstract
| Authors: | Cascone, T.; Awad, M. M.; Spicer, J.; He, J.; Lu, S.; Tanaka, F.; Cornelissen, R.; Petruzelka, L. B.; Ito, H.; De Oliveira Koch, L.; Wu, L.; Bohnet, S.; Erdmann, C. C.; Meadows-Shropshire, S.; Neely, J.; Hung, A.; Sathyanarayana, P.; Bhatia, S.; Provencio, M. |
| Abstract Title: | Perioperative nivolumab (NIVO) vs placebo (PBO) in patients (pts) with resectable NSCLC: Updated survival and biomarker analyses from CheckMate 77T |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 17 Suppl. |
| Meeting Dates: | 2025 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-10 |
| Start Page: | LBA8010 |
| Language: | English |
| ACCESSION: | WOS:001511751500001 |
| DOI: | 10.1200/JCO.2025.43.17_suppl.LBA8010 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
